Drug intelligence / Profile preview

BMS-770767

Development stage
Phase 2
Lead developer
Bristol Myers Squibb
Modality
Small Molecules
Administration
Oral
01

Overview

BMS-770767 is an investigational small molecule drug developed by Bristol Myers Squibb as an oral inhibitor of the enzyme 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1). This enzyme is widely expressed in the liver and other tissues and plays a key role in glucocorticoid metabolism. By inhibiting 11β-HSD1, BMS-770767 was intended to reduce local cortisol production and thereby improve metabolic parameters relevant to conditions such as type 2 diabetes and dyslipidemia. The compound has been studied in clinical trials for hypercholesterolemia (primary hypercholesterolemia/dyslipidemia), but there are no approved indications or known adverse events reported[1][3][5][6][7].

Other names
4-(8-(2-chlorophenoxy)(1,2,4)triazolo(4,3-a)pyridin-3-yl)bicyclo(2.2.1)heptan-1-ol
02

Targets

HSD11B1 (11-beta-hydroxysteroid dehydrogenase type 1)

Beyond the preview

Go deeper on BMS-770767.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BMS-770767.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call